Skip to main content

Select Drug Profiles

FDA Pipeline
Remaining FDA PDUFA Drug Approval Dates in 2024
Read More
Online First
FDA Approvals
FDA OKs Revumenib for Relapsed, Refractory Acute Leukemia With KMT2A Translocation
Read More
Disparities in Cancer Care, Oncology
IASLC Survey: Two Steps Forward, Two Steps Back in Lung Cancer Biomarker Testing
Read More
FDA Approvals
FDA OKs At-Home Influenza Vaccine
Read More
Online First
FDA Approvals
FDA OKs Lazertinib With Amivantamab-vmiw for NSCLC
Read More
NCI Initiatives
About the NCI Equity and Inclusion Program
Read More
Online Only
In-Depth Drug Profile
Treatment Breakthrough Changes Cystic Fibrosis Landscape
Katherine E Cilwa, PhD, Jayden Kim, PhD
Katherine E. Cilwa, PhD; Jayden Kim, PharmD
Read More
Disparities in Cancer Care, Oncology
Addressing Cancer Health Disparities: The No One Left Alone Initiative
Rohan Nathwani, Arva Patel, Warner Kornberg, Asutosh Gor, MD, Sashi Naidu, MD, Viral Rabara, MD, Niyati Nathwani, MD, Kashyap Patel, MD
Rohan Nathwani; Arva Patel; Warner Kornberg; Asutosh Gor, MD; Sashi Naidu, MD; Viral Rabara, MD; Niyati Nathwani, MD; Kashyap Patel, MD
Read More
Original Research
Provider and Payer Perspectives on the Impact of the COVID-19 Pandemic on Patients With Opioid Use Disorder: Multi-Stakeholder In-Depth Interviews
Maher Abdel-Sattar, PharmD, MS, FAMCP, Seth Cook, PharmD, MS, Ann Wheeler, PharmD, William Mullen, PA-C, MPH, Brett Alyson Maiese, PhD, MHS, Christian Heidbreder, PhD, MA, William Santoro, MD, FASAM, DABAM
Maher Abdel-Sattar, PharmD, MS, FAMCP; Seth Cook, PharmD, MS; Ann Wheeler, PharmD; William Mullen, PA-C, MPH; Brett Alyson Maiese, PhD, MHS; Christian Heidbreder, PhD, MA; William Santoro, MD, FASAM, DABAM
Read More
Breast Cancer, Oncology
Radiation May Be Safely Omitted in Favorable-Risk Breast Cancer Patients Aged 50 to 69 Years
Phoebe Starr
Read More
Page 4 of 244
Results 31 - 40 of 2434